Lester Kaplan

Lester J. Kaplan, Ph.D. has served as a director of ACADIA since November 1997. Dr. Kaplan was Executive Vice President and President, Research and Development at Allergan, Inc. from November 2003 to April 2004. Dr. Kaplan joined Allergan in 1983 and, prior to being appointed to Executive Vice President, was Corporate Vice President, Research and Development and Global BOTOX from June 1998 to November 2003. Dr. Kaplan was elected to Allergan's board of directors in 1994 and served in that capacity until April 2004. Dr. Kaplan is Executive Chairman of the Board of Aciex Therapeutics Inc., Chairman of the Board of Altheos, Inc., and a member of the Board of The National Neurovision Research Institute. He serves on the Scientific Advisory Board of Bay City Capital. Dr. Kaplan received a M.S. and Ph.D. in organic chemistry from the University of California, Los Angeles.

Lester Kaplan is the Board of Directors at Acadia Pharmaceuticals Inc.. With a background in Biotechnology, Lester Kaplan has a rich history of leadership and innovation. Lester Kaplan studied unknown Organic Chemistry @ University of California, Los Angeles. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.